• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌与胃肠道感染

Probiotics and gastrointestinal infections.

作者信息

Britton Robert A, Versalovic James

机构信息

Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI 48824, USA.

出版信息

Interdiscip Perspect Infect Dis. 2008;2008:290769. doi: 10.1155/2008/290769. Epub 2009 Feb 4.

DOI:10.1155/2008/290769
PMID:19277100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2648624/
Abstract

Gastrointestinal infections are a major cause of morbidity and mortality worldwide, particularly in developing countries. The use of probiotics to prevent and treat a variety of diarrheal diseases has gained favor in recent years. Examples where probiotics have positively impacted gastroenteritis will be highlighted. However, the overall efficacy of these treatments and the mechanisms by which probiotics ameliorate gastrointestinal infections are mostly unknown. We will discuss possible mechanisms by which probiotics could have a beneficial impact by enhancing the prevention or treatment of diarrheal diseases.

摘要

胃肠道感染是全球发病和死亡的主要原因,在发展中国家尤为如此。近年来,使用益生菌预防和治疗各种腹泻病受到青睐。将重点介绍益生菌对肠胃炎产生积极影响的实例。然而,这些治疗方法的总体疗效以及益生菌改善胃肠道感染的机制大多尚不清楚。我们将讨论益生菌通过加强腹泻病的预防或治疗可能产生有益影响的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4931/2648624/b37c26d4c17c/IPID2008-290769.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4931/2648624/b37c26d4c17c/IPID2008-290769.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4931/2648624/b37c26d4c17c/IPID2008-290769.001.jpg

相似文献

1
Probiotics and gastrointestinal infections.益生菌与胃肠道感染
Interdiscip Perspect Infect Dis. 2008;2008:290769. doi: 10.1155/2008/290769. Epub 2009 Feb 4.
2
Probiotics and gastrointestinal disease: successes, problems and future prospects.益生菌与胃肠道疾病:成就、问题与未来展望。
Gut Pathog. 2009 Nov 23;1(1):19. doi: 10.1186/1757-4749-1-19.
3
Probiotics and prebiotics in infectious gastroenteritis.感染性肠胃炎中的益生菌和益生元
Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):49-53. doi: 10.1016/j.bpg.2015.12.002. Epub 2015 Dec 19.
4
Probiotics, mechanisms of action, and clinical perspectives for diarrhea management in children.益生菌在儿童腹泻管理中的作用机制及临床应用
Food Funct. 2018 Oct 17;9(10):5074-5095. doi: 10.1039/c8fo00376a.
5
Prevention and Treatment of Neonatal Infections in Facility and Community Settings of Low- and Middle-Income Countries: A Descriptive Review.低收入和中等收入国家医疗机构及社区环境中新生儿感染的预防与治疗:描述性综述
Neonatology. 2025;122(Suppl 1):173-208. doi: 10.1159/000541871. Epub 2024 Nov 12.
6
Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens.了解益生菌抑制胃肠道病原体的机制。
Adv Food Nutr Res. 2009;56:1-15. doi: 10.1016/S1043-4526(08)00601-3.
7
Probiotics as prevention and treatment for diarrhea.益生菌用于腹泻的预防和治疗。
Curr Opin Gastroenterol. 2009 Jan;25(1):18-23. doi: 10.1097/MOG.0b013e32831b4455.
8
Probiotics and prebiotics in pediatric diarrheal disorders.益生菌和益生元在儿科腹泻疾病中的应用。
Expert Opin Pharmacother. 2013 Mar;14(4):397-409. doi: 10.1517/14656566.2013.771632. Epub 2013 Feb 13.
9
Probiotics for the developing world.面向发展中世界的益生菌
J Clin Gastroenterol. 2005 Jul;39(6):485-8. doi: 10.1097/01.mcg.0000165648.32371.38.
10
Role of probiotic as adjuvant in treating various infections: a systematic review and meta-analysis.益生菌作为辅助治疗各种感染的作用:系统评价和荟萃分析。
BMC Infect Dis. 2024 May 21;24(1):505. doi: 10.1186/s12879-024-09259-3.

引用本文的文献

1
The Anti-Inflammatory and Curative Exponent of Probiotics: A Comprehensive and Authentic Ingredient for the Sustained Functioning of Major Human Organs.益生菌的抗炎和治疗功效:主要人体器官持续功能的综合和纯正成分。
Nutrients. 2024 Feb 16;16(4):546. doi: 10.3390/nu16040546.
2
Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration Routes.抗菌药物在不同给药途径中实现选择性递送的药学方法的最新进展
Antibiotics (Basel). 2023 Apr 27;12(5):822. doi: 10.3390/antibiotics12050822.
3
Probiotics and their postbiotics for the control of opportunistic fungal pathogens: A review.

本文引用的文献

1
The efficacy of probiotics in IBS.益生菌在肠易激综合征中的疗效。
J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S85-90. doi: 10.1097/MCG.0b013e31816244ca.
2
Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice.无菌小鼠中肠出血性大肠杆菌所致肾脏疾病的发病机制
Infect Immun. 2008 Jul;76(7):3054-63. doi: 10.1128/IAI.01626-07. Epub 2008 Apr 28.
3
Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c-Jun.益生菌罗伊氏乳杆菌通过c-Jun抑制促炎细胞因子。
益生菌及其后生元对机会性真菌病原体的控制:综述
Biotechnol Rep (Amst). 2023 May 4;38:e00800. doi: 10.1016/j.btre.2023.e00800. eCollection 2023 Jun.
4
The Efficacy of Probiotics as Antiviral Agents for the Treatment of Rotavirus Gastrointestinal Infections in Children: An Updated Overview of Literature.益生菌作为抗病毒药物治疗儿童轮状病毒胃肠道感染的疗效:文献综述更新
Microorganisms. 2022 Dec 2;10(12):2392. doi: 10.3390/microorganisms10122392.
5
Effect of CNCM-I 3799 and CU-1 on Acute Watery Diarrhea: A Randomized Double-Blind Placebo-Controlled Study in Indian Children.法国国家微生物资源保藏中心菌株I 3799和CU-1对急性水样腹泻的影响:一项针对印度儿童的随机双盲安慰剂对照研究
Pediatr Gastroenterol Hepatol Nutr. 2021 Sep;24(5):423-431. doi: 10.5223/pghn.2021.24.5.423. Epub 2021 Sep 8.
6
Probiotic properties of - MYSRD 108 and MYSRD 71 with potential antimicrobial activity against .具有针对……潜在抗菌活性的 - MYSRD 108和MYSRD 71的益生菌特性。
Biotechnol Rep (Amst). 2021 Sep 6;32:e00672. doi: 10.1016/j.btre.2021.e00672. eCollection 2021 Dec.
7
Strain-Specific Probiotic Properties of Bifidobacteria and Lactobacilli for the Prevention of Diarrhea Caused by Rotavirus in a Preclinical Model.双歧杆菌和乳杆菌的菌株特异性益生菌特性可预防临床前模型中轮状病毒引起的腹泻。
Nutrients. 2020 Feb 15;12(2):498. doi: 10.3390/nu12020498.
8
Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.大肠杆菌 Nissle 1917 和 ECOR63 分泌的细胞外囊泡和可溶性因子可防止肠致病性大肠杆菌诱导的肠道上皮屏障功能障碍。
BMC Microbiol. 2019 Jul 17;19(1):166. doi: 10.1186/s12866-019-1534-3.
9
Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.口服益生菌唾液链球菌 K12 对人体耳及口腔健康的影响:系统评价。
Probiotics Antimicrob Proteins. 2017 Jun;9(2):102-110. doi: 10.1007/s12602-017-9261-2.
10
Deconjugated Bile Salts Produced by Extracellular Bile-Salt Hydrolase-Like Activities from the Probiotic La1 Inhibit Growth.由益生菌La1的细胞外胆汁盐水解酶样活性产生的去结合胆汁盐抑制生长。
Front Microbiol. 2016 Sep 27;7:1453. doi: 10.3389/fmicb.2016.01453. eCollection 2016.
Inflamm Bowel Dis. 2008 Aug;14(8):1068-83. doi: 10.1002/ibd.20448.
4
Inhibition of Neisseria gonorrhoeae epithelial cell interactions by vaginal Lactobacillus species.阴道乳酸杆菌对淋病奈瑟菌与上皮细胞相互作用的抑制作用。
Infect Immun. 2008 Jul;76(7):3124-30. doi: 10.1128/IAI.00101-08. Epub 2008 Apr 14.
5
Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling.益生菌罗伊氏乳杆菌通过调节核因子κB和丝裂原活化蛋白激酶信号通路促进肿瘤坏死因子诱导的人髓系白血病来源细胞凋亡。
Cell Microbiol. 2008 Jul;10(7):1442-52. doi: 10.1111/j.1462-5822.2008.01137.x. Epub 2008 Mar 7.
6
Probiotics for treatment of Clostridium difficile-associated colitis in adults.用于治疗成人艰难梭菌相关性结肠炎的益生菌
Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD004611. doi: 10.1002/14651858.CD004611.pub2.
7
Bile salts and glycine as cogerminants for Clostridium difficile spores.胆汁盐和甘氨酸作为艰难梭菌孢子的共萌发剂。
J Bacteriol. 2008 Apr;190(7):2505-12. doi: 10.1128/JB.01765-07. Epub 2008 Feb 1.
8
Genomic and genetic characterization of the bile stress response of probiotic Lactobacillus reuteri ATCC 55730.益生菌罗伊氏乳杆菌ATCC 55730胆汁应激反应的基因组和遗传特征分析
Appl Environ Microbiol. 2008 Mar;74(6):1812-9. doi: 10.1128/AEM.02259-07. Epub 2008 Feb 1.
9
Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function.鼠李糖乳杆菌GG菌株可预防肠出血性大肠杆菌O157:H7诱导的上皮屏障功能变化。
Infect Immun. 2008 Apr;76(4):1340-8. doi: 10.1128/IAI.00778-07. Epub 2008 Jan 28.
10
Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.复发性艰难梭菌相关性腹泻患者粪便微生物群的多样性降低。
J Infect Dis. 2008 Feb 1;197(3):435-8. doi: 10.1086/525047.